XT25XE5Monitoring of Kidney using Fluorescent Pyrazine, External Approach, New Technology Group 5
- Billable / Specific Code
XT25XE5 is a billable ICD-10-PCS procedure code for Monitoring of Kidney using Fluorescent Pyrazine, External Approach, New Technology Group 5. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). The root operation Monitoring involves determining the level of a physiological or physical function repetitively over a period of time.
Code Identity
PCS Table Breakdown
Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.
| Position | Designation | Value | Meaning |
|---|---|---|---|
| 1 | Section | X | New Technology |
| 2 | Body System | T | Urinary System |
| 3 | Operation | 2 | Monitoring |
| 4 | BodyPart | 5 | Kidney |
| 5 | Approach | X | External |
| 6 | Device/Substance/Technology | E | Fluorescent Pyrazine |
| 7 | Qualifier | 5 | New Technology Group 5 |
Code History
Similar Procedure Codes
Questions About XT25XE5
Is XT25XE5 a billable code?
Yes. XT25XE5 is a complete seven-character ICD-10-PCS code, specific enough to report Monitoring of Kidney using Fluorescent Pyrazine, External Approach, New Technology Group 5 on inpatient claims from October 1, 2025 through September 30, 2026.
What do the characters in XT25XE5 mean?
XT25XE5 breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character T is the Body System (Urinary System); the 3rd character 2 is the Operation (Monitoring); the 4th character 5 is the BodyPart (Kidney); the 5th character X is the Approach (External); the 6th character E is the Device/Substance/Technology (Fluorescent Pyrazine); the 7th character 5 is the Qualifier (New Technology Group 5).
